Xylocaine Injection, Solution
Product Images NDC 0404-9974

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 0404-9974). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure diagram of Lidocaine Hydrochloride (Lidocaine HCl), showing the molecular composition with labeled functional groups including aromatic rings, amide linkage, and ethyl groups attached to nitrogen, accompanied by the hydrochloride component.*

FDA Label Image

Formula2.jpg (Formula2)

Chemical structure diagram of the active ingredient Lidocaine HCl, showing the molecular arrangement of hydroxyl groups and amine groups attached to the aromatic ring and carbon backbone.*

FDA Label Image

Image1.jpg (Image1)

A table listing drug classes alongside examples. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Each class has corresponding drug examples, such as lidocaine under Local anesthetics and phenobarbital under Anticonvulsants.*

FDA Label Image

Image2.jpg (Image2)

A data table showing dosage information for Xylocaine (lidocaine hydrochloride) Injection without epinephrine. It lists various procedures such as infiltration, peripheral nerve blocks, paracervical, sympathetic nerve blocks, central neural blocks, and caudal. For each, it provides concentration percentages, volume ranges in mL, and total dose ranges in mg.*

FDA Label Image

Image3.jpg (Image3)

A data table listing multiple product codes, units of sale, strengths, and packaging details for Lidocaine HCl Injection, USP under the brand name Xylocaine. Strengths listed range from 0.5% to 2%, with vial sizes from 10 mL to 50 mL multiple-dose vials, and various National Drug Codes (NDCs) are provided for each product configuration.*

FDA Label Image

Image4.jpg (Image4)

A data table titled 'Xylocaine -MPF (lidocaine HCl Injection, USP)' showing multiple product codes, unit of sale, strength, and packaging details for lidocaine HCl injection in various concentrations (0.5%, 1%, 1.5%, 2%). It lists NDC numbers, unit sizes (units of 5 or 25), and packaging forms (single dose vials and plastic ampules) for each strength.*

FDA Label Image

Image5.jpg (Image5)

Table listing product codes, units of sale, strengths, and specific NDCs for various Xylocaine (Lidocaine HCl and epinephrine injection) formulations, including multiple dose vial sizes and concentrations of 0.5%, 1%, and 2% with different epinephrine ratios.*

FDA Label Image

Image6.jpg (Image6)

Table listing various product codes, units of sale, strengths, and associated NDCs for Xylocaine-MPF (lidocaine HCl and epinephrine injection). Strengths include 1%, 1.5%, and 2% solutions with vial sizes of 10 mL, 20 mL, and 30 mL, showing detailed NDC codes for single-dose vials and units of 5 or 25.*

FDA Label Image

Image7.jpg (Image7)

This text panel provides storage and handling instructions for a drug product, including discarding unused portions of single-dose vials and ampules, storing solutions at 20° to 25°C (68° to 77°F), and protecting from light. It includes a trademark note for Fresenius Kabi USA, LLC, along with their logo and website information, and a revision date of March 2019.*

FDA Label Image

Label1.jpg (Label1)

Label for Xylocaine 2% (Lidocaine HCl) Injection, USP multiple dose vial, 20 mg/mL strength, 50 mL volume. The label includes usage instructions for infiltration and nerve block, storage conditions at 20 to 25°C, and warnings about solution appearance. Packaged by Henry Schein, Inc., Dastian, VA.*

FDA Label Image

Label2.jpg (Label2)

Label for Xylocaine 2% (Lidocaine HCl) Injection USP, multiple-dose vial containing 400 mg/20 mL (20 mg/mL). The label states it is sterile, nonpyrogenic, for infiltration and nerve block use, not for caudal or epidural use. Manufactured and packaged by Henry Schein, Inc., with NDC 0404-9974-20 shown. Additional manufacturer and lot information areas are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.